- Home
- KAPA vs SOS Comparison
KAPA vs SOS Comparison
Compare KAPA & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAPA
- SOS
- Stock Information
- Founded
- KAPA 2013
- SOS 2004
- Country
- KAPA United States
- SOS China
- Employees
- KAPA N/A
- SOS N/A
- Industry
- KAPA
- SOS Finance: Consumer Services
- Sector
- KAPA
- SOS Finance
- Exchange
- KAPA NYSE
- SOS Nasdaq
- Market Cap
- KAPA 19.9M
- SOS 21.7M
- IPO Year
- KAPA 2024
- SOS 2017
- Fundamental
- Price
- KAPA $1.63
- SOS $7.51
- Analyst Decision
- KAPA Strong Buy
- SOS
- Analyst Count
- KAPA 1
- SOS 0
- Target Price
- KAPA $9.00
- SOS N/A
- AVG Volume (30 Days)
- KAPA 6.1M
- SOS 37.6K
- Earning Date
- KAPA 02-23-2025
- SOS 09-24-2024
- Dividend Yield
- KAPA N/A
- SOS N/A
- EPS Growth
- KAPA N/A
- SOS N/A
- EPS
- KAPA N/A
- SOS N/A
- Revenue
- KAPA N/A
- SOS $111,124,000.00
- Revenue This Year
- KAPA N/A
- SOS N/A
- Revenue Next Year
- KAPA N/A
- SOS N/A
- P/E Ratio
- KAPA N/A
- SOS N/A
- Revenue Growth
- KAPA N/A
- SOS N/A
- 52 Week Low
- KAPA $0.85
- SOS $5.95
- 52 Week High
- KAPA $4.00
- SOS $62.85
- Technical
- Relative Strength Index (RSI)
- KAPA N/A
- SOS 48.23
- Support Level
- KAPA N/A
- SOS $6.92
- Resistance Level
- KAPA N/A
- SOS $7.75
- Average True Range (ATR)
- KAPA 0.00
- SOS 0.52
- MACD
- KAPA 0.00
- SOS 0.18
- Stochastic Oscillator
- KAPA 0.00
- SOS 86.67
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.